Fda

132 results

ICON says its acquisition of Aptiv Solutions will enhance its capabilities in adaptive and medical device trials and in Japan.

Icon, the Dublin based provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has agreed t(...)

PTC Therapeutics said a committee of the European Medicines Agency recommended against a conditional approval to its drug for the treatment of a rare (...)

 X-Bolt Orthopaedics, founded by Dr Brian Thornes, has secured a €1.8 million investment to bring its hip fracture fixation product to a global market.  Photograph: Andres Poveda

Dublin-based X-Bolt Orthopaedics, a hip fracture fixation company, has secured €1.8 million in funding to bring the product to a global market. The fu(...)

Trustwater chief executive Edmond O’Reilly (centre) with The Irish Times InterTradeIreland 2013 Innovation Overall Winner Award. Also pictured (from left) are Thomas Hunter McGowan, chief executive of InterTradeIreland, Liam Kavanagh, managing director, The Irish Times, Kevin Keane (Trustwater) and Chris Horn, founder of IONA Technologies. photograph: arthur allison/pacemaker press

One of the most popular stands at this year’s Drinktec fair in Munich last September featured a breakthrough new cleaning and disinfection technology (...)

Amarin investors are getting decidedly twitchy. And with good reason. The Irish company this week goes before a US Food and Drug Administration panel (...)

Amarin has developed a drug called Vascepa which it says is a more effective cholesterol treatment than rival Lovaza

Shares in Irish drug firm Amarin have been hit by a US court ruling favouring generic pharmaceutical groups in the area where it operates.Teva Pharmac(...)

A man holds a sign referring to Colorado legalising marijuana in state capital   Denver.  Photograph: Rick Wilking/Reuters

Songs from Toni Fox’s preferred Rhonda Byrne CD flowed from her silver Saturn Vue as she sped past breathtaking mountain views during her twice-weekly(...)

It was the drug that launched a thousand quips. It not only propelled Pfizer into the public consciousness but put the company’s Irish headquarters an(...)

While Royalty Pharma boosted its unsolicited offer to as much as $15.50 a share this month, at least five analysts covering Dublin-based Elan see the stock falling if that bid disappears

Elan shareholders risk losing $2 billion by listening to the company’s board and rejecting Royalty Pharma’s takeover bid, according to market analysts(...)

Investors in pharmaceuticals businesses are a nervous bunch as Bruce Cozadd and his team at Dublin-based Jazz Pharmaceuticals discovered this w(...)

  • « First
  • Prev
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next
  • Last »